About
Pharmaceuticals
SEQENS is a global leader in pharmaceutical solutions and specialty ingredients. They provide a range of products, including generic and custom APIs, intermediates, and excipients for pharmaceuticals, along with ingredients for personal care and specialty chemicals. With 16 production sites and 9 R&D centers across 9 countries, SEQENS serves over 1,500 customers in more than 80 countries.
In 2021, Private equity group SK Capital Partners has completed the acquisition of a majority stake in French firm Seqens, at the same time merging portfolio company Wavelength Pharmaceuticals into Seqens.
Identity
| Name | SEQENS |
|---|---|
| Slug | seqens |
| Type / kind | multinational |
| Source _id | ow9tYK1l3AmhYN8oqMtQuPLuUihgQnk3OTTZx8y2hxwGws3ybGCpLL |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country | France |
|---|---|
| HQ country code | FR |
| HQ address | France |
Web & social
| Website | https://www.seqens.com/ |
|---|---|
| https://www.linkedin.com/company/12989492 |
Funding
| Total raised | — |
|---|
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}